Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate the safety, pharmacokinetics, and tolerability of ABI-1179 in healthy subjects and HSV-2 seropositive individuals with recurrent genit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Drugs mentioned

• ABI-1179

Snippet

Sponsor: Assembly Biosciences | Conditions: Recurrent Genital Herpes Simplex Type 2 | Phase 1 | Status: COMPLETED